Company Ticker: 6472 Company Name: Bora Industry: Biotechnology & Medical Care Data for: 2026-02 Monthly Revenue: 1,326,086 thousand NTD (1.326 billion) Year-over-Year Change: -23.2%
FACT BOX
- Source: PR Times
- Category: 其他
Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Feb 1, 2026 9:00 AM ・ Updated Jun 15, 2026 12:30 AM ・ 2 min read ・ Source: PR Times
Bora Pharmaceuticals released its revenue report for February 2026, posting NT$1.326 billion, a 23.2% decrease year-over-year. As a company specializing in pharmaceutical CDMO within the biotech and healthcare industry, this financial performance reflects the cyclical fluctuations of the sector.
Company Ticker: 6472 Company Name: Bora Industry: Biotechnology & Medical Care Data for: 2026-02 Monthly Revenue: 1,326,086 thousand NTD (1.326 billion) Year-over-Year Change: -23.2%
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.